Biogen Alzheimer’s drug moves to late stage trial

A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for Alzheimer’s disease to late-stage testing despite disappointing mid-stage trial data, the company said Thursday. Biogen said its experimental drug that targets tau, a protein associated with the memory-robbing disease, failed to show better responses at higher doses….

Read More

5 reasons why someone dislikes you

People dislike others for reasons that often have nothing to do with the person they target. It’s painful to be on the receiving end of coldness or criticism, especially when you’ve acted with integrity, kindness, or calm confidence. Yet understanding why someone dislikes you can be liberating: it shifts the focus from self-blame to clear…

Read More

Cisco (CSCO) pops on AI demand

Cisco CEO Chuck Robbins told CNBC on Thursday that skyrocketing demand for artificial intelligence tools and equipment is powering the industry toward a “networking supercycle.” Shares jumped 14% and headed for their best day in more than two decades after Cisco blew past its AI infrastructure and hyperscaler guidance orders for the fiscal year and lifted…

Read More